Abstract
INTRODUCTION
Numerous surgical treatment strategies for osteochondral lesions of the talus (OLT) have been proposed, but a universally ideal treatment has yet to be established [1, 2] . The operative treatment for OLT can be divided into two broad categories: Reparative and replacement procedures. Reparative procedures aim to regenerate tissue with biomechanical properties similar to normal hyaline cartilage. Bone marrow stimulation (BMS) is the most common reparative procedure, which stimulates mesenchymal stem cell proliferation and promotes fibrous cartilage repair tissue at the defect site. However, the fibrous cartilage repair tissue has different biological and mechanical properties compared to native hyaline cartilage and is likely to degenerate over time [3] . Auto logous chondrocyte implantation (ACI) is another re parative procedure that attempts to regenerate damaged cartilage with more hyalinelike repair tissue, but this procedure has the disadvantage of the need for a two staged intervention, which increases both cost and the potential for morbidity [4] . Recently, tissueengineering approaches using various types of bioavailable scaffolds has emerged with greater potential for cellular differentiation and maturation. The templates are typically seeded with elements selected to improve the quality of reparative cartilage and include stem cells and growth factors. Matrixinduced autologous chondrocyte transplantation (MACT) is a secondgene ration ACI technique, which uses a type Ⅰ/Ⅲ bilayer collagen membrane seeded with cultured autologous chondrocytes. However, MACT also requires a two stage procedure [5, 6] . Autologous matrixinduced chondrogenesis (AMIC) is a onestep scaffoldbased therapy that combines bone marrow stimulation (BMS) with the use of a porcine collagen Ⅰ/Ⅲ matrix scaffold [7] . Bone marrowderived cell transplantation (BMDCT) is also a onestep procedure and is a combination of concentrated bone marrow aspirate and scaffold material [8] . Scaffoldbased therapy for OLT offers alternative reparative procedures and is quickly becoming more popular as data supporting clinical efficacy increases [9] . However, no consensus has been reached regarding the effectiveness of scaffoldbased therapy on OLT to date.
The purpose of the current systematic review was to clarify the effectiveness of scaffoldbased therapy for OLT based on available clinical evidence.
MATERIALS AND METHODS

Search strategy
Two independent reviewers performed a systematic review of the databases PubMed/MEDLINE and EMBASE in January 2017 based on the Preferred Reporting Items for Systematic Reviews and MetaAnalyses (PRISMA) guidelines [10] . The combination of search terms were: (cartilage OR cartilage injury OR cartilage damage OR cartilage repair OR cartilage defect OR osteochondral lesion OR osteochondral dissecans OR osteochondral defect OR osteochondral injury OR osteochondral fracture OR osteochondritis dissecans) AND (ankle OR talus OR tibia OR talocrural joint) AND (scaffold OR scaffoldbased repair OR matrixassisted chondrocyte implantation OR cartilage regeneration OR osteochondral repair). The reference list of all articles and relevant studies were also scanned for additional articles potentially not identified through our electronic search alone.
The inclusion and exclusion criteria are shown in the Table 1 . No time limit was given to publication date.
The titles and abstracts were reviewed by applying the aforementioned criteria, and the full text of potentially relevant studies was then selected. Scaffoldbased therapy for OLT was defined as operative treatment using any scaffolds for OLT.
Differences between reviewers were discussed until agreement was achieved, and the senior author was consulted in the event of persistent disagreement.
Assessment of level of evidence
Two independent investigators reviewed each study and the LOE was determined using previously published criteria [11] .
Assessment of methodological quality of evidence
Two independent investigators evaluated the metho dological quality of evidence (QOE) of the included studies using the Modified Coleman Methodology Score (MCMS) ( Table 2 ) [12, 13] . Instances of discrepancy were resolved by consensus and if any disagreement persisted, a senior author was consulted and a consensus was reached. Excellent studies were considered those that scored 85 to 100 points; good studies scored 70 to 84 points; fair studies scored 55 to 69 points, and poor studies scored less than 55 points [14] .
Data extraction and analysis
Two reviewers independently extracted data from each study and assessed variable reporting of outcome data using parameters of previously published criteria [15] . In addition, clinical outcomes and the percentage of patients who returned to sport at previous level were evaluated.
Statistical analysis
All statistical analysis was performed using a com mercially available statistical software package (SAS 9.3; SAS Institute, Inc., Cary, NC, United States). Descriptive statistics were calculated for each study and parameters analyzed. For each variable, the number and percentage of studies that reported the variable was calculated. Variables were reported as weighted average ± weighted standard deviation where applicable.
RESULTS
After full text review, 28 clinical studies for a total of 897 ankles were identified for inclusion in the current study ( Figure 1 ) [48, 1638] . The weighted mean followup was 37.7 (range 687) mo, with only three studies reporting a follow-up time of greater than five years [20, 22, 24] . Of the 28 clinical studies, there were 30 treatment groups, including six different scaffoldbased therapies: 13 MACT [5, 6, 1626] , nine BMDCT [4, 8, 2631] , four AMIC [7, 3234] , two cartilage extracellular matrix [35, 36] , one autologous collageninduced chondrogenesis (ACIC) [37] , and one cell free scaffold therapy [38] . All included studies of scaffoldbased therapy were summarized in Table 3 . Patient demographics and clinical characteristics of each procedure are shown in Table 4 .
LOE
There was one (3.6%) study of LOE Ⅱ [30] , three studies (10.7%) of LOE Ⅲ [4, 24, 26] , and 24 studies (85.7%) of LOE Ⅳ [58, 1623, 25, 2729, 3138] (Table 5 ) according to established criteria [11] . No study of LOE I was reported. The further data of LOE in each procedure group was shown in Table 5 .
QOE
The weighted mean MCMS of the overall population of studies was 49.3 ± 10.0 out of a possible 100 points. There were seven studies (25%) of fair [5] ,
2010
Case series Ⅳ 10 1.3 24 Significant clinical improvement at 1 yr and maintained at 2 yr Aurich et al [16] , 2011
Case series Ⅳ 18 -25 Significant improvement in all clinical scores 64% were excellent or good Age and symptoms duration were correlated with results Dixon et al [17] , 2011
Case series Ⅳ 25 1.3 44 72% improved symptoms 78% patients over 40 yr reported restricted recreational activity Lee et al [18] ,
2013
Case series Ⅳ 38 1.9 24 Functional outcomes improved significantly at 2 yr 68% were excellent or good outcome 75% ICRS grade I or II in 2 nd look arthroscopy at 1 yr Johnson et al [19] , 2013
Case series Ⅳ 18 1.9 82 Functional outcomes improved at final follow-up Giannini et al [20] , 2014
Case series Ⅳ 46 1.6 87 Significant clinical improvement at 1 yr and maintained at 3 yr; 3 failures Hyalograft C Giannini et al [21] , 2008
Case series Ⅳ 46 1.6 36 Significant clinical improvement at 1 yr and 3 yr Results correlated with age and previous surgery Hyaline-like cartilage regeneration in histological evaluation Battaglia et al [22] , 2011
Case series Ⅳ 20 2.7 60 Significant clinical improvement T2 mapping MRI showed 69% of lesion are covered with repair tissue Nehrer et al [23] , 2011
Case series Ⅳ 13 -47 Significant clinical improvement in all cases Domayer et al [24] , 2012
Comparative study
Significant clinical improvement but no significant difference compared to MFX group No difference between MFX and MACT on T2 maps Apprich et al [25] , 2012 Giannini et al [26] , 2010
39 57
Significant clinical improvement at 1 yr and further improvement at 3 yr 76% complete intergration with surrounding cartilage on MRI Hyaline-like cartilage tissue on histological evaluation HYAFF- 11 Battaglia et al [27] , 2011
Case series Ⅳ 20 1.5 24 85% excellent or good clinical results at 2 yr 78% of lesion are covered with repair tissue comparable to hyaline cartilage Spontostan Powder HYAFF- 11 Giannini et al [28] , 2013
Case series Ⅳ 49 2.1 29 Significant clinical improvement at 1 yr with subsequent significant decrease at 2 and 3 yr 78% of repaired tissue similar to hyaline cartilage on T2 maps Spongostan Powder
Buda et al [29] , 2014 data is shown in Table 5 .
Variable reporting of outcome data
The defined data that were reported in the studies included in this review are listed and the each data according to procedure group is shown in Table 6 . General demographic information including age and gender were reported in 93% of the studies. While the study design, imaging data, and patientreported outcomes were wellreported variables with 73%, 73% and 85% respectively, patient history was the least reported variable of all with 30% of the data being reported. Clinical variables were reported in only 49% of studies. Clinical outcomes were evaluated using a number of different scoring systems for scaffoldsbased therapy for OLT ( Table 7) . The American Orthopaedic Foot and Ankle Society (AOFAS) score was the most frequently utilized in 25 studies of the included [48, 1618, 2034, 37, 38] . Of the 25 studies that used AOFAS, 22 studies investigated both pre and postoperative scores [48, 16, 18, 2023, 2532, 34, 37, 38] . Twelve of 13 MACT groups reported pre and post operative AOFAS scores and of the 310 patients who underwent MACT [5, 6, 1618, 2026] , the mean AOFAS score improved from 59.1 to 86.7 at a mean followup of 47.9 mo. Of the 416 patients from the nine BMDCT groups [4, 8, 2631] , the mean AOFAS score improved from 61.1 to 88.2 at a mean of 32.7 mo of followup. Of the 126 patients from the four AMIC groups [7, 3234] , the mean AOFAS score improved from 50.7 to 82.3 at a mean followup of 38.2 mo. Of the two cartilage ECM studies included, one publication reported outcomes at less than one year followup [36] , and the other one did not describe clinical outcomes [35] . There was only one publication reporting ACIC data but clinical evaluation was in sufficient due to a follow-up of only six mo [37] . In the cell free scaffold group, only one study was published, which showed no clinical improvement in AOFAS score at a mean 30 mo (from 48.7 to 52.7) follow-up. However, these results only included four studies [38] . In this systematic review, 12 procedure groups reported sequential clinical outcomes at two or more postoperative time points [4, 5, 8, 18, 20, 21, 26, 2831] . Four gr oups, which were all BMDCT studies, found temporal improvement in AOFAS scores over the first 2-3 years of postoperative followup with a mean decrease in AOFAS score of 87.1 reported at a mean 41.8 mo followup [4, 28, 29, 31] . In contrast, eight groups, including four MACT and four BMDCT groups, demonstrated that there were no deteriorations during a weighted mean 38mo followup [5, 8, 18, 20, 21, 26, 30] .
Return to sport activity at previous level
Overall, eight studies (MACT: One study, AMIC: Two [4, 8, 21, 28, 29, 31, 32, 34] . Of the MACT procedures, Giannini et al [21] showed that 20 of 29 patients (69%) returned to sport at previous levels. In patients treated with AMIC procedures, Valderrabano et al [32] reported only nine of 20 patients (45%) returned to previous sport activity level, and Wiewiorski et al [34] also showed no significant difference when comparing preoperative and postoperative activity scores (ARS, Tegner). BMDCT was the most reported in five studies, and of these studies, 74.5% of patients were able to resume sports at preinjury level, with a range of 69% to 78% [4, 8, 28, 29, 31] .
DISCUSSION
The results from this systematic review demonstrate that recommendations for scaffoldbased therapy based solely on evidence is not yet conclusive. In the current evaluation, 96% of included studies in which scaffold based therapy was performed for the treatment of OLT were classified into the category of poor LOE. In addition, of 28 included articles, no papers were of good or better methodological quality. According to the principles of evidencebased medicine [39] , a high level of clinical evidence and good methodological quality are fundamentally warranted to treat patients because low LOE and QOE studies are more likely to show overestimated outcomes compared to higher LOE and QOE studies [40, 41] . Careful attention therefore should be paid when evaluating outcomes following the studies of scaffoldbased therapy for OLT.
The results from the current systematic review demon strate large variability and underreporting of clinical data between studies reflecting and inability to compare the results across studies. These inconsistencies and general underreporting of data make it difficult to pool data, which furthermore makes it difficult to draw conclusions about effectiveness of the use of scaffold in the treatment for OLT. As Hannon et al [15] described, adequate reporting of data in the studies of the treatment for OLT should be required to perform high quality studies, and investigators should be encouraged to implement data collection both before and after surgery according to recommended list described by Hannon et al [15] in this review, the categories of imaging data were reported in 73% of included studies. Compared with reporting of outcome data on microfracture for OLT in the systematic review by Hannon et al [15] , imaging data was reported in only 39% among the studies. However, this review showed a higher percentage of reporting of imaging data (73%). Nevertheless, only 67% of studies used MRI for patient followup evaluation, although MRI evaluation for scaffoldbased treatment of OLT is crucial because the aim of the use of scaffolds and is generally believed to promote the subchondral bone and cartilage repair. In addition, the categories of clinical variables and patient history were reported only with 49% and 30% respectively. As these data including BMI, lesion location, presence of cyst, associated pathology, and concomitant procedures can have significant effect on patient outcome, what is alarming is that appropriate information is not enough taken in the current studies.
Lesion size has been widely accepted as the most commonly used predictor of clinical outcomes after BMS for OLT [42, 43] . Choi et al [42] demonstrated that BMS should be indicated for lesions less than 150 mm 2 and lesions greater than this value resulted in poor outcomes. More recently, Ramponi et al [13] suggested that BMS could be best reserved for lesion size of less than 107.4 mm 2 rather than 150 mm 2 . In the current review, however, the mean lesion size treated with scaffolds was 215 mm 2 , which is much larger than traditional indication size for BMS or the most current new indication size of 107 mm 2[13] . This suggests that the use of scaffolds may further improve the potential of reparative techniques. However, further well-designed studies are necessary to determine the effectiveness of scaffoldbased therapy on OLT because of low LOE and QOE and the large variability in the data.
Despite of high frequency of OLT in the athletic population, little is reported regarding return to sport following surgical treatment of OLT in this population. In the current review, weighted mean 68.3% of patients receiving scaffold therapy with weighted mean 250 mm 2 of lesion size returned to previous sport activity at previous level in eight studies. There are no studies investigating the effectiveness of BMS alone for athletic populations who have large lesion as described above, but Choi et al [42] reported clinical failure rate in patients with lesion area ≥ 150 mm 2 was 80%. Furthermore, Chuckpaiwong et al [43] reported a 97% of failure rate in 32
patients with a lesion area ≥ 150 mm 2 . This suggests that the use of scaffolds may provide better outcomes than BMS alone for larger lesions but high quality studies are warranted. On the other hand, in replacement procedures, including autologous osteochondral transplantation, which is generally indicated for larger lesions, several studies reported that more than 90% of patients returned to play sport at previous levels [44, 45] . Although there is inconsistency in indications for the treatment strategy, the rate of return to sport following scaffoldbased therapy appears to be relatively lower than AOT procedures. The highest rate of return to sport after scaffoldbased therapy was only 78.0% in athletes treated with BMDCT [31] . However, there was variability of sport type, postoperative rehabilitation protocol, and time to return to sport, which makes it difficult to assess these results appropriately.
Our review found that there were 12 different sco ring systems used to assess clinical outcomes, with AOFAS score being the most commonly used (89%). However, there remains no validated scoring system for the clinical followup for the treatment of OLT [13] . Moreover, four BMDCT groups have shown that clinical outcomes deteriorate after peaking at 23 year post operatively [4, 28, 29, 31] , whereas four MACT and four BMDCT groups have no deterioration during followup [5, 8, 18, 20, 21, 26, 30] . A potential reason for these lags in clinical outcome data may be the invalid clinical evaluation methods after OLT surgery in addition to the use of the different kinds of scaffolds. A novel validated scoring system for the clinical followup of the treatment for OLT are currently warranted.
The appropriate treatment for OLT is still contro versial. While the ideal procedure would regenerate a tissue with biomechanical properties similar to normal hyaline cartilage, reparative techniques can offer the replacement of the articular cartilage with a hyaline like repair tissue. Scaffolds have been introduced to improve the requirements of the cartilage regeneration process, as ACI, the first generation approach for cartilage treatment, has evident biological and surgical limitations [46] . In fact, the use of scaffolds has overcome the drawbacks and simplified the procedure. However, any available substitute materials have not yet matched the properties of the normal cartilage, and there is no consensus about the superior effectiveness of these procedures over the other procedures, including replacement procedures. While the scaffoldbased treatment has shown promising clinical results in numerous studies of case series, the current systematic review showed low LOE and poor methodological quality of the use of scaffolds for OLT. Further longterm comparative studies are warranted to investigate the potential of a bioengineered approach compared to other treatments. Furthermore, the definitive indications for this technique, including lesion size and character of the lesion, still remains controversial [13] . This systematic review has several inherent limi tations and/or potential biases. The criterion was limited to MEDLINE, EMBASE and Cochrane Library Database articles published exclusively in English. The variables may not be all inclusive of data in each study, but they should be a representative summary of the most commonly used data. Another inherent concern was the overlapping of cohorts or subgroups of several cohorts studies in longitudinal followup studies. Finally, the data extraction was not performed blindly, but was performed by two independent reviewers and later confirmed by the lead author.
In conclusion, this systematic review demonstrated that the scaffoldbased therapy for the treatment of OLT may produce favorable clinical outcomes, but low level of evidence, poor quality of evidence, and the variability of the data have confounded the effectiveness of scaffoldbased therapy for OLT. Further, welldesigned studies, are necessary to determine the effectiveness of the use of scaffold for the treatment of OLT, especially when compared to available traditional treatments.
COMMENTS
Background
Recently scaffold-based therapy for osteochondral lesions of the talus (OLT) has become more popular as an alternative reparative procedure. However, no consensus has been reached regarding the effectiveness of scaffold-based therapy in the treatment of OLT to date. In this study, the effectiveness of scaffold-based therapy was systematically reviewed based on available clinical evidence.
Research frontiers
Scaffolds have been introduced to improve the requirements of the cartilage regeneration process, as autologous chondrocyte implantation (ACI), the first generation approach for cartilage treatment, has evident biological and surgical limitations. Recently, the use of scaffolds has overcome the drawbacks and simplified the procedure.
Innovations and breakthroughs
The scaffold-based treatment has shown promising clinical results in numerous studies of case series and the use of scaffolds may further improve the potential of reparative techniques. Retrieved manuscripts were reviewed by the authors, and the data were extracted.
Applications
This systematic review suggests that the scaffold-based therapy for the Shimozono Y et al . Scaffolds based therapy for osteochondral lesions of the talus COMMENTS treatment of OLT may produce favorable clinical outcomes, but low level of evidence, poor quality of evidence, and the variability of the data have confounded the effectiveness of scaffold-based therapy for OLT.
Terminology
Matrix-induced autologous chondrocyte transplantation is a second-generation ACI technique, which uses a type Ⅰ/Ⅲ bilayer collagen membrane seeded with cultured autologous chondrocytes. Autologous matrix-induced chondrogenesis is a one-step scaffold-based therapy that combines bone marrow stimulation with the use of a porcine collagen Ⅰ/Ⅲ matrix scaffold. Bone marrow-derived cell transplantation is also a one-step procedure and is a combination of concentrated bone marrow aspirate and scaffold material.
